GHFT - Prescribing tolvaptan for autosomal dominant polycystic kidney disease

GHFT - Prescribing tolvaptan for autosomal dominant polycystic kidney disease featured image
  • Acute
  • Acute > Clinical Support
  • Acute > Clinical Support > Pharmacy
  • Acute > Medicine
  • Acute > Medicine > General Internal Medicine
  • Leadership and Management
  • Leadership and Management > Quality and Performance
  • Leadership and Management > Quality and Performance > QI
  • Campaigns
  • Campaigns > #FabChange19
02 April 2024

RCHT QI Conference ED Discharge Summaries

25 March 2024

Elevating Medical Education Through Standardised Bedside Teaching

Menu
This website uses cookies to ensure you get the best experience on our website.
Manage Preferences
Download acrobat reader